title: Coming into focus. Pharmacologic treatment for ADHD.
authors.affiliation: South Shore Psychiatric Services, Marshfield, MA, USA.
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: McDonnell
authors.forename: Christie
authors.initials: C
authors.lastname: Moffett
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D015897:Comorbidity; D003692:Delayed-Action Preparations; D016903:Drug Monitoring; D006801:Humans; D000077408:Modafinil; D010389:Pemoline / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000928:Antidepressive Agents; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D010389:Pemoline; D000077408:Modafinil